VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
ST Nanxin (688189.SH): Phase III Clinical Trial of Peramivir Inhalation Solution Achieves Primary Endpoint
ST Nanxin (688189.SH): Phase III Clinical Trial of Peramivir Inhalation Solution Achieves Primary Endpoint
Jun 11, 2026 18:00 CST Updated 18:32
Share:
